These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3733275)

  • 1. Effect of age on the pharmacokinetics of indobufen.
    Savazzi GM; Castiglioni A; Cavatorta A; Garini G; Montanari M; Borghetti A
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):265-9. PubMed ID: 3733275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dispositional enantioselectivity of indobufen in man.
    Strolm Benedetti M; Frigerio E; Tamassia V; Noseda G; Caldwell J
    Biochem Pharmacol; 1992 May; 43(9):2032-4. PubMed ID: 1596290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man.
    Fuccella LM; Corvi G; Moro E; Pogliani E; Tamassia V; Tosolini G
    Eur J Clin Pharmacol; 1979 Jun; 15(5):323-7. PubMed ID: 456403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indobufen (K 3920), a new inhibitor of platelet aggregation: effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man.
    Tamassia V; Corvi G; Fuccella LM; Moro E; Tosolini G; Tremoli E
    Eur J Clin Pharmacol; 1979 Jun; 15(5):329-33. PubMed ID: 456404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation.
    Vinazzer H; Fuccella LM
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):316-25. PubMed ID: 7400367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of indobufen compared with aspirin in patients with coronary atherosclerosis.
    Yang M; Ye Z; Mei L; Ullah I; Tan C; Wang G; Gu Q; Lu Y; Abdus S; Shi L; Gong X; Bai J; Eikelboom JW; Li C
    Eur J Clin Pharmacol; 2021 Dec; 77(12):1815-1823. PubMed ID: 34331551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation in man by indobufen (K 3920).
    Vittoria A; Laghi Pasini F; Messa GL; Di Perri T; Corvi G; Fuccella LM
    J Int Med Res; 1981; 9(1):12-7. PubMed ID: 7202826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-thromboglobulin and platelet factor 4 plasma levels during haemodialysis: effect of indobufen.
    Pogliani EM; Colombi M; Cristoforetti G; Valenti G; Miradoli R; Buccianti G
    Pharmatherapeutica; 1982; 3(2):127-32. PubMed ID: 6179101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dispositional enantioselectivity of indobufen in rat and mouse.
    Strolin Benedetti M; Moro E; Frigerio E; Jannuzzo MG; Roncucci R; Caldwell J
    Biochem Pharmacol; 1990 Oct; 40(8):1719-23. PubMed ID: 2242009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk.
    Mannucci L; Maderna P; Colli S; Lavezzari M; Sirtori CR; Tremoli E
    Thromb Res; 1987 Nov; 48(4):417-26. PubMed ID: 3445229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different patterns of inhibition of adrenaline-induced platelet aggregation and kinetics in vivo by acetylsalicylic acid and indobufen.
    Fortunato JS; Pinheiro MJ; Monteiro MC; Rodrigues MA; Amaral I
    J Int Med Res; 1991; 19(4):305-17. PubMed ID: 1916004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and ex vivo effects of indobufen on human platelet aggregation, the release reaction and thromboxane B2 production.
    Cattaneo M; Bevilacqua C; Lecchi A; Mannucci PM
    Haemostasis; 1987; 17(5):293-300. PubMed ID: 3666587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
    Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
    Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory activity of indobufen (*) on platelet aggregation in vivo.
    Bergamaschi M; Pierucci L; Branzoli U
    Pharmacol Res Commun; 1984 Oct; 16(10):979-85. PubMed ID: 6438651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiaggregant effect of indobufen (K3920) measured by the platelet aggregate filtration pressure test (PAFP).
    Visonà A; Davanzo S; Bruno R; Pagnan A
    J Int Med Res; 1983; 11(1):10-4. PubMed ID: 6832462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man.
    De Caterina R; Sicari R; Yan A; Bernini W; Giannessi D; Lazzerini G; Efthymiopoulos C; Strolin-Benedetti M
    Thromb Haemost; 1992 Feb; 67(2):258-63. PubMed ID: 1621247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of racemic, S- and R-indobufen on cyclooxygenase and lipoxygenase activities in human whole blood.
    Patrignani P; Volpi D; Ferrario R; Romanzini L; Di Somma M; Patrono C
    Eur J Pharmacol; 1990 Nov; 191(1):83-8. PubMed ID: 1965501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state pharmacokinetics of indobufen enantiomers in patients with obliterative atherosclerosis.
    Glówka FK; Strzelecka D; Zapalski S
    Chirality; 2001 Jun; 13(6):308-12. PubMed ID: 11370020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.